From Liston Street Pulse:
Tetraphase Pharmaceuticals, Inc. (TTPH) recently announced that it is ready for Phase 3 clinical trial for its Eravacycline IV and oral drug. The drug on trial is for urinary tract infections. The company outlines Phase 3 for Eravacycline and shows that it will be the second phase of Phase 3. […]
The post Tetraphase Pharmaceuticals on Phase 3 for Eravacycline appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015